R&D Advantages
Integrate global resources to address unmet clinical needs for patients worldwide, develop world‑leading innovative medical products, and build core competitiveness of closed-loop R&D.
-
Precise target identification and validation capabilities
Leveraging big data and expert resources, we proactively identify and track global cutting-edge targets, dynamically evaluate future trends, and select early-stage projects that are globally aligned or leading. -
A highly specialized translational medicine system
We build systematic toolkits covering early-stage research to clinical translation, identify novel biomarkers, explore innovative clinical surrogate endpoints, and accelerate the clinical development process and improve efficiency of our product. -
Top-tier clinical development capabilities
Leveraging high‑end clinical medical resources, we formulates efficient clinical development strategies, pathways, trial designs, implementation plans and cost scenarios to comprehensively improve the overall cost‑benefit of clinical development.
Technology Platform
Drug Development and Evaluation Agents
Leveraging our profound expertise in drug R&D and evaluation, and integrating Artificial Intelligence with biotechnology, we have developed innovative AI Agents. The R&E Agent provides intelligent, end-to-end solutions spanning the entire chain from target assessment and drug evaluation to regulatory submission.
-
Target Assessment
-
Drug Evaluation
-
Regulatory Submission.
Pipeline
